We are live on
!
Find out more
MCM
Marathon Capital Management Portfolio holdings
AUM
$494M
1-Year Est. Return
42.6%
This Fund
S&P 500
This Quarter
Est. Return
+6.52%
1 Year Est. Return
+42.6%
3 Year Est. Return
+70.91%
5 Year Est. Return
+55.81%
10 Year Est. Return
+429.8%
AUM
$212M
AUM Growth
+$10.3M
(+5.1%)
Cap. Flow
+$2.18M
Cap. Flow
% of AUM
1.03%
Top 10 Holdings %
Top 10 Hldgs %
68.35%
Holding
95
New
8
Increased
27
Reduced
24
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Public Storage
PSA
|
+$3.02M |
| 2 |
ORBC
ORBCOMM, Inc.
ORBC
|
+$1.74M |
| 3 |
CVA
Covanta Holding Corporation
CVA
|
+$1.46M |
| 4 |
ENZ
Enzo Biochem, Inc.
ENZ
|
+$1.07M |
| 5 |
Bank of America Series L
BAC.PRL
|
+$527K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$1.77M |
| 2 |
T. Rowe Price
TROW
|
+$1.46M |
| 3 |
GIMO
Gigamon Inc.
GIMO
|
+$1.01M |
| 4 |
CFMS
Conformis, Inc. Common Stock
CFMS
|
+$831K |
| 5 |
HDSN
Hudson Technologies
HDSN
|
+$776K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 50.28% |
| 2 | Technology | 15.94% |
| 3 | Industrials | 6.88% |
| 4 | Healthcare | 5.57% |
| 5 | Consumer Discretionary | 5.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Cameco
CCJ
$38.4B
| $137K | 0.06% |
15,000
| – | – |
|
77
Lattice Semiconductor
LSCC
$16.4B
| $133K | 0.06% |
20,000
| – | – |
|
|
CFMS
78
DELISTED
Conformis, Inc. Common Stock
CFMS
| $122K | 0.06% |
1,139
-6,919
| -86% | -$831K |
|
|
XONE
79
DELISTED
The ExOne Company
XONE
| $115K | 0.05% |
10,000
| – | – |
|
80
Kopin
KOPN
$663M
| $91K | 0.04% |
24,500
-10,000
| -29% | -$37.6K |
|
81
Cerus
CERS
$621M
| $90K | 0.04% |
36,000
+11,500
| +47% | +$36.8K |
|
|
BSQR
82
DELISTED
BSQUARE Corporation
BSQR
| $84K | 0.04% |
15,000
| – | – |
|
|
WPRT
83
Westport Fuel Systems
WPRT
$33.8M
| $78K | 0.04% |
3,300
| – | – |
|
84
Hecla Mining
HL
$10B
| $64K | 0.03% |
12,500
| – | – |
|
85
Plus Therapeutics
PSTV
$25.8M
| – | – |
0
| – | – |
|
|
ESNC
86
DELISTED
EnSync Inc
ESNC
| $9K | ﹤0.01% |
25,000
| – | – |
|
87
Sphere 3D
ANY
$14.4M
| $2K | ﹤0.01% |
1
| – | – |
|
88
Aviat Networks
AVNW
$263M
| – | – |
-24,500
| Closed | -$184K |
|
89
ConocoPhillips
COP
$142B
| – | – |
-4,025
| Closed | -$201K |
|
90
Opko Health
OPK
$921M
| – | – |
-15,000
| Closed | -$120K |
|
91
Qorvo
QRVO
$7.83B
| – | – |
-3,000
| Closed | -$206K |
|
92
Scorpio Tankers
STNG
$3.88B
| – | – |
-1,200
| Closed | -$53K |
|
93
AT&T
T
$167B
| – | – |
-6,604
| Closed | -$207K |
|
|
94
Weyerhaeuser
WY
$17.3B
| – | – |
-52,045
| Closed | -$1.77M |
|
|
GIMO
95
DELISTED
Gigamon Inc.
GIMO
| – | – |
-28,300
| Closed | -$1.01M |
|
Similar funds
LI
SAS
BFIC
BPIA
FSA
TAM
CH
TAA
Marathon Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, Marathon Capital Management held 95 positions worth $212M, up 5.1% from $202M the previous quarter. Its ten largest holdings account for 68% of the portfolio.
Marathon Capital Management's Q2 2017 filing shows 8 new, 27 increased, 24 reduced and 8 closed positions. Its largest new stake was Public Storage: 14,050 shares worth $368K. The largest sale was Weyerhaeuser, an estimated $1.77M.
By sector, the portfolio is most concentrated in Financials at 50% of assets, up from 49% a quarter earlier, followed by Technology and Industrials.
- Marathon Capital Management's largest Q2 2017 buy was Public Storage: 14,050 shares worth $368K.
- Marathon Capital Management added most to Frontier Communications Corp. in Q2 2017, an estimated $231K increase.
- Marathon Capital Management's biggest Q2 2017 reduction was T. Rowe Price, cutting an estimated $1.46M.
- Marathon Capital Management fully exited Weyerhaeuser in Q2 2017, selling an estimated $1.77M.
- Marathon Capital Management's ten largest holdings make up 68% of its $212M portfolio in Q2 2017.
- Marathon Capital Management opened 8 new positions and closed 8 in Q2 2017.
- Marathon Capital Management's portfolio value rose 5.1% quarter-over-quarter to $212M.
Based on Marathon Capital Management's 13F filing for Q2 2017, filed 10 Aug 2017.